Scandion Oncology

Overcoming cancer drug resistance

Navbar
  • About us
    • Executive Management
    • Board of Directors
    • Clinical Advisory Board
  • Research & Development
    • Pipeline
    • Clinical Development
    • Science
      • Cancer drug resistance
      • Technology Platform
      • SCO-101
  • Press releases
  • Investors & Media
    • Share information
    • Financial Reports
      • Annual reports
      • Interim reports
      • Year-end reports
    • Presentations
    • Media
      • Image library
      • Video library
    • Analyst Coverage
    • Prospectuses
      • Rights Issue 2022
      • Rights Issue 2020
      • Rights Issue 2019
      • Subscription Warrant (SCOL TO 1)
      • IPO 2018
    • Corporate governance
    • Events
      • Financial calendar
      • General meetings
  • Contact
    • Career
    • Business development
Skip to content
Regulatory
28 October 2022

Press releases

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
AllAnnual reportInterim ReportNewsNewsletterPress releaseYear end reportRegulatory posts
28 October 2022 Scandion Oncology Announces Results of Extraordinary General Meeting Download Presentation Webcast Workbook
27 April 2022 Scandion Oncology Announces Results of Annual General Meeting and Constitution of the Board of Directors Download Presentation Webcast Workbook
1 December 2021 Scandion Oncology announce minutes of Extraordinary General Meeting Download Presentation Webcast Workbook
26 May 2021 Scandion Oncology A/S: Minutes of the Annual General Meeting 2021 Download Presentation Webcast Workbook
13 November 2020 Correction: Scandion Oncology – Minutes of extraordinary general meeting Download Presentation Webcast Workbook
13 November 2020 Scandion Oncology – Minutes of extraordinary general meeting Download Presentation Webcast Workbook
2 October 2020 Communique from the Extraordinary General Meeting of Scandion Oncology A/S Download Presentation Webcast Workbook
11 June 2019 Communique from the Extraordinary General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
31 May 2019 Communique from the Annual General Meeting of Scandion Oncology A/S Download Presentation Webcast Workbook
  1. Frontpage

About us

  • About us
  • Executive Management
  • Board of Directors
  • Clinical Advisory Board

Research & Development

  • Research & Development
  • Pipeline
  • Clinical Development
  • Science

Investors & Media

  • Investors & Media
  • Share information
  • Financial Reports
  • Presentations
  • Media
  • Analyst Coverage
  • Prospectuses
  • Corporate governance
  • Events

Contact us

Scandion Oncology A/S
Symbion
Fruebjergvej 3
2100 Copenhagen
Denmark

Phone: +45 38 10 20 17
info@scandiononcology.com

Media and Investor relations:
Email: ir@scandiononcology.com
Phone: +45 29 60 35 32

Follow us


Scandion Oncology - The Cancer Drug Resistance Company

Our vision is to overcome cancer drug resistance in order to improve lives for cancer patients and their families

© Copyright 2022 - Scandion Oncology A/S | We use cookies to improve our services | Disclaimer: Market data could be delayed. Delivered by Cision.